Neuropathy of the Facial Nerve

Case Study: Neuropathy of the Facial Nerve

A 38-year-old female patient presented to the clinic with a previously established diagnosis of left-sided facial nerve neuropathy and moderate facial palsy. At the time of the initial examination, the patient reported several persistent symptoms, including lacrimation on the left side, periodic facial pain, and noticeable facial asymmetry. Additionally, the patient was unable to fully close her left upper eyelid, which would only shut halfway.

The patient’s clinical history indicated that she had been suffering from this condition for approximately four months. Prior to seeking coMra therapy, she had undergone two courses of inpatient treatment at her place of residence, which resulted in only partial improvement.

The coMra Therapy Treatment Plan

The patient began a structured coMra therapy protocol to address her symptoms. The treatment was divided into two distinct courses:

* First Course: The patient received 10 treatments, administered twice daily at the clinic. * Second Course: Following a one-month interval after the first course, the patient continued treatment at home for nine days, also performing sessions twice daily.

Clinical Results and Progress

The patient reported significant progress throughout the treatment process. Following the first course, she noted a partial improvement in her condition. Specifically, the pain had subsided, the corner of her mouth had begun to level off, and the facial palsy showed signs of reduction.

The patient observed tangible improvements as early as the fourth session of the first course. During this time, the corner of her mouth began to rise more effectively, allowing her to smile. Her upper eyelid also demonstrated improved mobility, and her facial pain decreased significantly. By the conclusion of the first course, the pain had disappeared entirely, the corner of her mouth on the left side had aligned with the healthy side, and her lacrimation had decreased. The eyelid function continued to improve, showing better range of motion.

During the interval between the first and second courses, the patient experienced no recurrence of pain, and there was no regression of her symptoms.

Following the second course of coMra therapy, the results were even more pronounced. The pain did not return, and the lacrimation had completely resolved. The mouth area on the left side had leveled off entirely, and the facial palsy had decreased significantly compared to the results observed after the first course. Furthermore, the patient’s eyelid was nearly capable of closing the eye completely.

The patient was advised to continue coMra therapy after a two-to-three-week rest period, with subsequent sessions to be determined based on her ongoing condition.